Study: Combination of Two Immunotherapies Brings Advanced Melanoma Survival Rate up to 50% for First
By combining two existing therapies, researchers found that they have been able to stop or reverse the progression of advanced melanoma.
top of page
it's where dermatology lives
Featured Posts
bottom of page